Lonza Group


November 27, 2021

Lonza Group is a chemical industry group headquartered in Basel, Switzerland. Lonza is mainly involved in pharmaceutical and biopharmaceutical chemistry.


Lonza was founded in 1897 in the small town of Gampel, in the canton of Valais, named after the nearby river in the Lötschental. It initially produced electricity, then calcium carbonate with furnaces at 2000 ° C for calcium oxide. Lonza moved to Visp in 1909. In 1915 the production of calcium cyanamide for fertilizer began. Various acquisitions from 1962 followed, such as the Ftalital of Scanzorosciate. In 1969, the American headquarters of Lonza Inc. in Fair Lawn, NJ. In 1974 the merger with Alusuisse took place. In 1980 Lonza began the production of polymers in Milan, and the acquisition of the San Giovanni Valdarno plant. In 1985 Molding Compounds S.p.A. was acquired. of Brembate Sopra.

Covid-19 vaccine

In May 2020, Moderna signs an agreement to manufacture the COVID-19 vaccine (mRNA-1273). Production of the vaccine began in January 2021, after approval by the Swiss authorities. Lonza Group is responsible for two-thirds of the number of vaccines produced worldwide in its US and Swiss plants. The company also collaborates with Altimmune Inc. to develop the nasal vaccine for COVID-19.

Corporate structure

Lonza Life Science Ingredients (LSI) Lonza Microbial Control (LMC) Lonza Custom Manufacturing (LCM) Lonza Bioscience (LBS)


INSERT INTO `wiki_article`(`id`, `article_id`, `title`, `article`, `img_url`) VALUES ('NULL()','Lonza_Group','Lonza Group','